{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:36:09Z","timestamp":1789972569534,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,9,5]],"date-time":"2015-09-05T00:00:00Z","timestamp":1441411200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s11302-015-9467-2","type":"journal-article","created":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T22:47:46Z","timestamp":1441406866000},"page":"481-490","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Paroxetine suppresses recombinant human P2X7 responses"],"prefix":"10.1007","volume":"11","author":[{"given":"Phuong","family":"Dao-Ung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen K.","family":"Skarratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,5]]},"reference":[{"issue":"5","key":"9467_CR1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1399-0039.2011.01780.x","volume":"78","author":"JS Wiley","year":"2011","unstructured":"Wiley JS et al (2011) The human P2X7 receptor and its role in innate immunity. Tissue Antigens 78(5):321\u2013332","journal-title":"Tissue Antigens"},{"issue":"7","key":"9467_CR2","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.4049\/jimmunol.176.7.3877","volume":"176","author":"D Ferrari","year":"2006","unstructured":"Ferrari D et al (2006) The P2X7 receptor: a key player in IL-1 processing and release. J Immunol (Baltimore, Md : 1950) 176(7):3877\u20133883","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"5","key":"9467_CR3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1074-7613(01)00229-1","volume":"15","author":"A MacKenzie","year":"2001","unstructured":"MacKenzie A et al (2001) Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15(5):825\u2013835","journal-title":"Immunity"},{"issue":"1","key":"9467_CR4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R et al (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9(1):46\u201356","journal-title":"Nat Rev Neurosci"},{"key":"9467_CR5","unstructured":"Miller AH, Maletic V, Raison CL (2010) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry: 1\u201310"},{"key":"9467_CR6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1741-7015-10-66","volume":"10","author":"M Maes","year":"2012","unstructured":"Maes M et al (2012) Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med 10:66","journal-title":"BMC Med"},{"issue":"4","key":"9467_CR7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/ajmg.b.30303","volume":"141B","author":"N Barden","year":"2006","unstructured":"Barden N et al (2006) Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 141B(4):374\u2013382","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"16","key":"9467_CR8","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1093\/hmg\/ddl166","volume":"15","author":"S Lucae","year":"2006","unstructured":"Lucae S et al (2006) P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum Mol Genet 15(16):2438\u20132445","journal-title":"Hum Mol Genet"},{"issue":"6","key":"9467_CR9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/mp.2008.6","volume":"14","author":"A McQuillin","year":"2009","unstructured":"McQuillin A et al (2009) Case-control studies show that a non-conservative amino-acid change from a glutamine to arginine in the P2RX7 purinergic receptor protein is associated with both bipolar- and unipolar-affective disorders. Mol Psychiatry 14(6):614\u2013620","journal-title":"Mol Psychiatry"},{"issue":"4","key":"9467_CR10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ajmg.b.31179","volume":"156B","author":"P Soronen","year":"2011","unstructured":"Soronen P et al (2011) P2RX7 gene is associated consistently with mood disorders and predicts clinical outcome in three clinical cohorts. Am J Med Genet B Neuropsychiatr Genet 156B(4):435\u2013447","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"8","key":"9467_CR11","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/ajmg.b.30931","volume":"150B","author":"EK Green","year":"2009","unstructured":"Green EK et al (2009) P2RX7: a bipolar and unipolar disorder candidate susceptibility gene? Am J Med Genet B Neuropsychiatr Genet 150B(8):1063\u20131069","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"7","key":"9467_CR12","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/ajmg.b.30952","volume":"150B","author":"M Grigoroiu-Serbanescu","year":"2009","unstructured":"Grigoroiu-Serbanescu M et al (2009) Variation in P2RX7 candidate gene (rs2230912) is not associated with bipolar I disorder and unipolar major depression in four European samples. Am J Med Genet B Neuropsychiatr Genet 150B(7):1017\u20131021","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"3","key":"9467_CR13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2011.02.023","volume":"493","author":"M Viikki","year":"2011","unstructured":"Viikki M et al (2011) P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT. Neurosci Lett 493(3):127\u2013130","journal-title":"Neurosci Lett"},{"issue":"8","key":"9467_CR14","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1096\/fj.09-150862","volume":"24","author":"L Stokes","year":"2010","unstructured":"Stokes L et al (2010) Two haplotypes of the P2X(7) receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1beta secretion. FASEB J 24(8):2916\u20132927","journal-title":"FASEB J"},{"key":"9467_CR15","unstructured":"Basso A et al. (2008) Behavioral profile of P2X7 receptor knockout mice in animal models of depression, anxiety: relevance for neuropsychiatric disorders. Behav Brain Res: 46"},{"key":"9467_CR16","unstructured":"Csolle C et al. (2012) The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice. Int J Neuropsychopharmacol: 1\u201321"},{"key":"9467_CR17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fncel.2015.00258","volume":"9","author":"L Stokes","year":"2015","unstructured":"Stokes L, Spencer SJ, Jenkins TA (2015) Understanding the role of P2X7 in affective disorders\u2014are glial cells the major players? Front Cell Neurosci 9:258","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"9467_CR18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1124\/pr.110.003129","volume":"63","author":"C Coddou","year":"2011","unstructured":"Coddou C et al (2011) Activation and regulation of purinergic P2X receptor channels. Pharmacol Rev 63(3):641\u2013683","journal-title":"Pharmacol Rev"},{"issue":"3","key":"9467_CR19","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/pr.113.008003","volume":"66","author":"R Bartlett","year":"2014","unstructured":"Bartlett R, Stokes L, Sluyter R (2014) The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease. Pharmacol Rev 66(3):638\u2013675","journal-title":"Pharmacol Rev"},{"issue":"8","key":"9467_CR20","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/sj.bjp.0701081","volume":"120","author":"CE Gargett","year":"1997","unstructured":"Gargett CE, Wiley JS (1997) The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes. Br J Pharmacol 120(8):1483\u20131490","journal-title":"Br J Pharmacol"},{"issue":"9","key":"9467_CR21","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0028-3908(97)00141-X","volume":"36","author":"C Virginio","year":"1997","unstructured":"Virginio C et al (1997) Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neuropharmacology 36(9):1285\u20131294","journal-title":"Neuropharmacology"},{"issue":"6","key":"9467_CR22","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/sj.bjp.0705868","volume":"142","author":"AN Shemon","year":"2004","unstructured":"Shemon AN et al (2004) Chelerythrine and other benzophenanthridine alkaloids block the human P2X7 receptor. Br J Pharmacol 142(6):1015\u20131019","journal-title":"Br J Pharmacol"},{"issue":"3","key":"9467_CR23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bbrc.2007.11.008","volume":"365","author":"AN Shemon","year":"2008","unstructured":"Shemon AN et al (2008) Inhibition of the human P2X7 receptor by a novel protein tyrosine kinase antagonist. Biochem Biophys Res Commun 365(3):515\u2013520","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"9467_CR24","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/sj.bjp.0706938","volume":"149","author":"AD Michel","year":"2006","unstructured":"Michel AD et al (2006) Species and response dependent differences in the effects of MAPK inhibitors on P2X(7) receptor function. Br J Pharmacol 149(7):948\u2013957","journal-title":"Br J Pharmacol"},{"issue":"2","key":"9467_CR25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/jpet.108.146365","volume":"328","author":"W Ma","year":"2009","unstructured":"Ma W et al (2009) Pharmacological characterization of pannexin-1 currents expressed in mammalian cells. J Pharmacol Exp Ther 328(2):409\u2013418","journal-title":"J Pharmacol Exp Ther"},{"issue":"13","key":"9467_CR26","doi-asserted-by":"crossref","first-page":"11067","DOI":"10.1074\/jbc.M110.198879","volume":"286","author":"W Norenberg","year":"2011","unstructured":"Norenberg W et al (2011) Clemastine potentiates the human P2X7 receptor by sensitizing it to lower ATP concentrations. J Biol Chem 286(13):11067\u201311081","journal-title":"J Biol Chem"},{"issue":"3","key":"9467_CR27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093058","volume":"9","author":"A Bhaskaracharya","year":"2014","unstructured":"Bhaskaracharya A et al (2014) Probenecid blocks human P2X7 receptor-induced dye uptake via a pannexin-1 independent mechanism. PLoS ONE 9(3), e93058","journal-title":"PLoS ONE"},{"key":"9467_CR28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1744-8069-5-20","volume":"5","author":"K Nagata","year":"2009","unstructured":"Nagata K et al (2009) Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief. Mol Pain 5:20","journal-title":"Mol Pain"},{"key":"9467_CR29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.neuropharm.2013.07.027","volume":"75","author":"C Hempel","year":"2013","unstructured":"Hempel C et al (2013) The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor. Neuropharmacology 75:365\u2013379","journal-title":"Neuropharmacology"},{"issue":"4","key":"9467_CR30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1017\/S1461145702003164","volume":"5","author":"G Kenis","year":"2002","unstructured":"Kenis G, Maes M (2002) Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacol 5(4):401\u2013412","journal-title":"Int J Neuropsychopharmacol"},{"issue":"7","key":"9467_CR31","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1476-5381.2009.00233.x","volume":"157","author":"DL Donnelly-Roberts","year":"2009","unstructured":"Donnelly-Roberts DL et al (2009) Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors. Br J Pharmacol 157(7):1203\u20131214","journal-title":"Br J Pharmacol"},{"issue":"2b","key":"9467_CR32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1476-5381.2011.01399.x","volume":"164","author":"HJ Bradley","year":"2011","unstructured":"Bradley HJ et al (2011) Pharmacological properties of the rhesus macaque monkey P2X7 receptor. Br J Pharmacol 164(2b):743\u2013754","journal-title":"Br J Pharmacol"},{"issue":"5","key":"9467_CR33","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/bjp.2008.306","volume":"155","author":"AD Michel","year":"2008","unstructured":"Michel AD et al (2008) Identification of regions of the P2X(7) receptor that contribute to human and rat species differences in antagonist effects. Br J Pharmacol 155(5):738\u2013751","journal-title":"Br J Pharmacol"},{"issue":"8","key":"9467_CR34","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1476-5381.2009.00135.x","volume":"156","author":"AD Michel","year":"2009","unstructured":"Michel AD et al (2009) Mechanism of action of species-selective P2X(7) receptor antagonists. Br J Pharmacol 156(8):1312\u20131325","journal-title":"Br J Pharmacol"},{"key":"9467_CR35","doi-asserted-by":"crossref","unstructured":"Toulme E et al. (2010) On the role of ATP-gated P2X receptors in acute, inflammatory and neuropathic pain. In: Kruger L, Light AR (Eds) Translational pain research: from mouse to man. Boca Raton, FL","DOI":"10.1201\/9781439812105-c10"},{"issue":"6950","key":"9467_CR36","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nature01786","volume":"424","author":"M Tsuda","year":"2003","unstructured":"Tsuda M et al (2003) P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424(6950):778\u2013783","journal-title":"Nature"},{"issue":"14","key":"9467_CR37","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1038\/emboj.2010.126","volume":"29","author":"L Ulmann","year":"2010","unstructured":"Ulmann L, Hirbec H, Rassendren F (2010) P2X4 receptors mediate PGE2 release by tissue-resident macrophages and initiate inflammatory pain. EMBO J 29(14):2290\u20132300","journal-title":"EMBO J"},{"issue":"1","key":"9467_CR38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1527-3458.2001.tb00189.x","volume":"7","author":"M Bourin","year":"2001","unstructured":"Bourin M, Chue P, Guillon Y (2001) Paroxetine: a review. CNS Drug Rev 7(1):25\u201347","journal-title":"CNS Drug Rev"},{"issue":"27","key":"9467_CR39","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1021\/bi100536t","volume":"49","author":"HR Arias","year":"2010","unstructured":"Arias HR et al (2010) Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors. Biochemistry 49(27):5734\u20135742","journal-title":"Biochemistry"},{"issue":"12","key":"9467_CR40","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.mp.4001314","volume":"8","author":"B Eisensamer","year":"2003","unstructured":"Eisensamer B et al (2003) Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Mol Psychiatry 8(12):994\u20131007","journal-title":"Mol Psychiatry"},{"issue":"4","key":"9467_CR41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jpain.2006.10.001","volume":"8","author":"IE Dick","year":"2007","unstructured":"Dick IE et al (2007) Sodium channel blockade may contribute to the analgesic efficacy of antidepressants. J Pain 8(4):315\u2013324","journal-title":"J Pain"},{"issue":"3","key":"9467_CR42","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1254\/jphs.FP0060708","volume":"102","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Washiyama K, Ikeda K (2006) Inhibition of G protein-activated inwardly rectifying K+ channels by the antidepressant paroxetine. J Pharmacol Sci 102(3):278\u2013287","journal-title":"J Pharmacol Sci"},{"issue":"7","key":"9467_CR43","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/npp.2010.27","volume":"35","author":"T Kobayashi","year":"2010","unstructured":"Kobayashi T, Washiyama K, Ikeda K (2010) Inhibition of G-protein-activated inwardly rectifying K+ channels by the selective norepinephrine reuptake inhibitors atomoxetine and reboxetine. Neuropsychopharmacology 35(7):1560\u20131569","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20133","key":"9467_CR44","first-page":"19","volume":"592","author":"SH Jo","year":"2008","unstructured":"Jo SH et al (2008) Clomipramine block of the hERG K+ channel: accessibility to F656 and Y652. Eur J Pharmacol 592(1\u20133):19\u201325","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"9467_CR45","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1124\/jpet.102.044834","volume":"304","author":"RT Robinson","year":"2003","unstructured":"Robinson RT, Drafts BC, Fisher JL (2003) Fluoxetine increases GABA(A) receptor activity through a novel modulatory site. J Pharmacol Exp Ther 304(3):978\u2013984","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"9467_CR46","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjp.0707625","volume":"153","author":"AD Michel","year":"2008","unstructured":"Michel AD, Chambers LJ, Walter DS (2008) Negative and positive allosteric modulators of the P2X(7) receptor. Br J Pharmacol 153(4):737\u2013750","journal-title":"Br J Pharmacol"},{"issue":"7","key":"9467_CR47","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/sj.bjp.0706933","volume":"149","author":"L Stokes","year":"2006","unstructured":"Stokes L et al (2006) Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373. Br J Pharmacol 149(7):880\u2013887","journal-title":"Br J Pharmacol"},{"issue":"4","key":"9467_CR48","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1085\/jgp.200910336","volume":"135","author":"E Toulme","year":"2010","unstructured":"Toulme E et al (2010) P2X4 receptors in activated C8-B4 cells of cerebellar microglial origin. J Gen Physiol 135(4):333\u2013353","journal-title":"J Gen Physiol"},{"issue":"2","key":"9467_CR49","first-page":"150","volume":"1","author":"M Mahmoodi","year":"2009","unstructured":"Mahmoodi M et al (2009) Effect of trifluoperazine on carrageenan-induced acute inflammation in intact and adrenalectomized rats. Int J Physiol Pathophysiol Pharmacol 1(2):150\u2013153","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"issue":"1","key":"9467_CR50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1124\/jpet.107.132167","volume":"325","author":"F Luo","year":"2008","unstructured":"Luo F et al (2008) Reversal of chronic inflammatory pain by acute inhibition of Ca2+\/calmodulin-dependent protein kinase II. J Pharmacol Exp Ther 325(1):267\u2013275","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"9467_CR51","first-page":"94","volume":"18","author":"M Zarei","year":"2014","unstructured":"Zarei M, Sabetkasaei M, Moini Zanjani T (2014) Paroxetine attenuates the development and existing pain in a rat model of neurophatic pain. Iran Biomed J 18(2):94\u2013100","journal-title":"Iran Biomed J"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-015-9467-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11302-015-9467-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-015-9467-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T06:15:08Z","timestamp":1567145708000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11302-015-9467-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,5]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["9467"],"URL":"https:\/\/doi.org\/10.1007\/s11302-015-9467-2","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,5]]}}}